Given that Parkinsonism due to DNAJC12-deficiency is dopa-responsive, supplementation with levodopa/carbidopa is an established therapeutic to both treat and potentially prevent this manifestation [17]. This evidence concerns the gene DNAJC12 and Parkinson disease.